Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

Learn how the benefits of GLP-1s may be outweighed by the risks.

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

"Real Housewives of New Jersey" star Dolores Catania candidly shared her experience with taking weight loss medication and ...

The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...

This is only a glimpse of the data available to CivicScience clients. Discover more data. It’s safe to say that GLP-1 ...

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...

Fibromyalgia patients taking GLP-1s have lower rates of opioid use, pain, fatigue, and malaise in a real-world patient data ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Here’s a roundup of numbers from the last week of HR news — including the percentage of managers who use AI to help determine ...

DoseSpot, which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions for healthcare providers, announced today the results of a new data analysis on 102, ...